CompletedNot Applicable

Efficacy of Noninvasive Radiofrequency in Attenuating Diabetic Neuropathic Pain

Egypt23 participantsStarted 2023-06-07

Plain-language summary

Peripheral neuropathy increases the prevalence of diabetic foot ulcers following a decrease in foot sensation. Therefore, the treatment of this disorder is very important.

Who can participate

Age range40 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 40-70 years * Type II DM with DPN (grade I-II) in lower limbs * Duration of DM\>5 years * Visual Analog Scale (VAS) ≥3 in the feet * Sensory impairments in the lower extremities Exclusion Criteria: * Patient with previous stenting or surgical intervention of lower limb arterial system. * Patients with previous history of DVT. * Pregnancy * Diabetic infectious wound * Cardiac pacemaker presence * Severe liver and kidney dysfunction or history of heart and lung disease.

What they're measuring

Change of the perfusion index at the end of the first session compared to baseline readings.

Timeframe: 40 minutes

Trial details

NCT IDNCT05917249

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-01

View on ClinicalTrials.gov More Diabetic Neuropathy, Painful trials